BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30924566)

  • 1. Reproducibility of human cardiac phosphorus MRS (
    Ellis J; Valkovič L; Purvis LAB; Clarke WT; Rodgers CT
    NMR Biomed; 2019 Jun; 32(6):e4095. PubMed ID: 30924566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
    Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T.
    Tyler DJ; Emmanuel Y; Cochlin LE; Hudsmith LE; Holloway CJ; Neubauer S; Clarke K; Robson MD
    NMR Biomed; 2009 May; 22(4):405-13. PubMed ID: 19023865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
    Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
    Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of human cardiac 31P-NMR spectroscopy.
    Lamb HJ; Doornbos J; den Hollander JA; Luyten PR; Beyerbacht HP; van der Wall EE; de Roos A
    NMR Biomed; 1996 Aug; 9(5):217-27. PubMed ID: 9068003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy.
    Nakae I; Mitsunami K; Yabe T; Inubushi T; Morikawa S; Matsuo S; Koh T; Horie M
    J Cardiovasc Magn Reson; 2004; 6(3):685-96. PubMed ID: 15347133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
    Kemp GJ; Meyerspeer M; Moser E
    NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.
    Yabe T; Mitsunami K; Inubushi T; Kinoshita M
    Circulation; 1995 Jul; 92(1):15-23. PubMed ID: 7788910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.
    Bakermans AJ; Abdurrachim D; van Nierop BJ; Koeman A; van der Kroon I; Baartscheer A; Schumacher CA; Strijkers GJ; Houten SM; Zuurbier CJ; Nicolay K; Prompers JJ
    NMR Biomed; 2015 Oct; 28(10):1218-27. PubMed ID: 26269430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field dependence study of in vivo brain (31) P MRS up to 16.4 T.
    Lu M; Chen W; Zhu XH
    NMR Biomed; 2014 Sep; 27(9):1135-41. PubMed ID: 25070004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional, 2.5-minute, 7T phosphorus magnetic resonance spectroscopic imaging of the human heart using concentric rings.
    Clarke WT; Hingerl L; Strasser B; Bogner W; Valkovič L; Rodgers CT
    NMR Biomed; 2023 Jan; 36(1):e4813. PubMed ID: 35995750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of three-dimensional chemical shift imaging (3D-CSI)--a study of 3D-CSI in the human heart and its clinical perspectives for the future].
    Yabe T; Mitsunami K; Inubushi T
    Nihon Rinsho; 1997 Jul; 55(7):1839-43. PubMed ID: 9233037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of phosphocreatine to ATP ratio in normal and diseased human heart by 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique.
    Rajagopalan B; Blackledge MJ; McKenna WJ; Bolas N; Radda GK
    Ann N Y Acad Sci; 1987; 508():321-32. PubMed ID: 3439707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla.
    Rodgers CT; Clarke WT; Snyder C; Vaughan JT; Neubauer S; Robson MD
    Magn Reson Med; 2014 Aug; 72(2):304-15. PubMed ID: 24006267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cardiac (31)P MRS at 1.5 and 3 T.
    Tyler DJ; Hudsmith LE; Clarke K; Neubauer S; Robson MD
    NMR Biomed; 2008 Oct; 21(8):793-8. PubMed ID: 18512846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition-weighted chemical shift imaging improves SLOOP quantification of human cardiac phosphorus metabolites.
    Geier O; Weng AM; Toepell A; Hahn D; Spindler M; Beer M; Köstler H
    Z Med Phys; 2014 Mar; 24(1):49-54. PubMed ID: 23375741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiabatic excitation for
    Valkovič L; Clarke WT; Purvis LAB; Schaller B; Robson MD; Rodgers CT
    Magn Reson Med; 2017 Nov; 78(5):1667-1673. PubMed ID: 28000961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Cardiac
    Bakermans AJ; Bazil JN; Nederveen AJ; Strijkers GJ; Boekholdt SM; Beard DA; Jeneson JAL
    Front Physiol; 2017; 8():939. PubMed ID: 29230178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart.
    Friedrich J; Apstein CS; Ingwall JS
    Circulation; 1995 Dec; 92(12):3527-38. PubMed ID: 8521576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.